Literature DB >> 31792758

Kidney transplant patient with immunoglobulin A nephropathy subsequently diagnosed as concurrent autosomal dominant polycystic kidney disease during 17-year follow-up.

Joichi Usui1, Hirayasu Kai2, Shuzo Kaneko2, Mayumi Takahashi-Kobayashi3, Masahiro Hagiwara2,4, Kazuhiro Takahashi5, Tatsuya Oda5, Kunihiro Yamagata2.   

Abstract

A 14-year-old Japanese boy was diagnosed with immunoglobulin A nephropathy resulting in end-stage kidney disease (ESKD). He underwent ABO-compatible living kidney transplantation from his father at the age of 27. In the process of selecting a donor before the transplantation, it turned out that his mother had polycystic kidneys and that her family had a history of hypertension and cerebrovascular diseases. The patient himself also had bilateral multiple kidney cysts, with a normal-sized kidney, confusing us to make the diagnosis of acquired cystic kidney disease (ACKD) or ADPKD difficult at that point. Seventeen years later, his native kidneys showed bilateral swelling with multiple cysts. This, along with the histories of his mother and her relatives and with the existence of multiple liver cysts, led us to confirm the diagnosis of autosomal dominant polycystic kidney disease, not of ACKD. Contrary to previous studies that have suggested the size of cysts both in ADPKD and ACKD reduced with time, the present case showed an increase of 3.0% per year in total kidney volume (TKV) by computed tomography. It suggested the possibility that TKV, after decreasing in the relatively early stage after transplantation, may later increase in the long term after ESKD due to another kidney injury.

Entities:  

Keywords:  Autosomal dominant polycystic kidney disease; End-stage kidney disease; Immunoglobulin A nephropathy; Kidney transplantation; Total kidney volume

Mesh:

Year:  2019        PMID: 31792758      PMCID: PMC7148390          DOI: 10.1007/s13730-019-00436-x

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  11 in total

1.  Volume regression of native polycystic kidneys after renal transplantation.

Authors:  Yeonsoon Jung; María V Irazabal; Fouad T Chebib; Peter C Harris; Patrick G Dean; Mikel Prieto; Fernando G Cosio; Ziad M El-Zoghby; Vicente E Torres
Journal:  Nephrol Dial Transplant       Date:  2015-06-04       Impact factor: 5.992

2.  Regression of acquired cystic disease of the kidney after successful renal transplantation.

Authors:  I Ishikawa; T Yuri; H Kitada; A Shinoda
Journal:  Am J Nephrol       Date:  1983 Nov-Dec       Impact factor: 3.754

3.  Kidney volume changes in patients with autosomal dominant polycystic kidney disease after renal transplantation.

Authors:  Takayuki Yamamoto; Yoshihiko Watarai; Takaaki Kobayashi; Yoshiko Matsuda; Makoto Tsujita; Takahisa Hiramitsu; Koji Nanmoku; Norihiko Goto; Akio Katayama; Yoshihiro Tominaga; Kazuharu Uchida
Journal:  Transplantation       Date:  2012-04-27       Impact factor: 4.939

Review 4.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

5.  Strategies to inhibit cyst formation in ADPKD.

Authors:  James P Calvet
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-23       Impact factor: 8.237

6.  IgA nephropathy and polycystic kidney disease.

Authors:  J M Panisello; A Martinez-Vea; C Garcia; M Carrera; J A Oliver; C Richart
Journal:  Am J Nephrol       Date:  1988       Impact factor: 3.754

Review 7.  Diagnostic approach in autosomal dominant polycystic kidney disease.

Authors:  York Pei
Journal:  Clin J Am Soc Nephrol       Date:  2006-08-09       Impact factor: 8.237

8.  Volume changes in polycystic kidneys during chronic dialysis and after renal transplantation.

Authors:  J H Thaysen; H S Thomsen; A Sass; J K Kristensen
Journal:  Acta Med Scand       Date:  1985

Review 9.  Nephrotic syndrome and autosomal dominant polycystic kidney disease.

Authors:  Bianca Visciano; Renata A Di Pietro; Roberta Rossano; Antonio Mancini; Pasquale Zamboli; Bruno Cianciaruso; Antonio Pisani
Journal:  Clin Kidney J       Date:  2012-11-11

10.  Evidence-based clinical practice guidelines for polycystic kidney disease 2014.

Authors:  Shigeo Horie; Toshio Mochizuki; Satoru Muto; Kazushige Hanaoka; Yoshimitsu Fukushima; Ichiei Narita; Kikuo Nutahara; Ken Tsuchiya; Kazuhiko Tsuruya; Koichi Kamura; Saori Nishio; Tatsuya Suwabe; Yoshifumi Ubara; Eiji Ishimura; Koichi Nakanishi; Keiichi Furukawa; Kenjiro Kimura; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2016-08       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.